Report Detail

Pharma & Healthcare Global Adult and Pediatric Vaccines Market Growth (Status and Outlook) 2019-2024

  • RnM3128216
  • |
  • 14 March, 2019
  • |
  • Global
  • |
  • 134 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

A vaccine is a biological preparation that provides active acquired immunity to a particular disease.

According to this study, over the next five years the Adult and Pediatric Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Adult and Pediatric Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Adult and Pediatric Vaccines market by product type, application, key companies and key regions.

This study considers the Adult and Pediatric Vaccines value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Adult Vaccines
Pediatric Vaccines
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Medical Care Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
Sinovac Biotech

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Adult and Pediatric Vaccines market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Adult and Pediatric Vaccines market by identifying its various subsegments.
Focuses on the key global Adult and Pediatric Vaccines players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Adult and Pediatric Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Adult and Pediatric Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Adult and Pediatric Vaccines Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Adult and Pediatric Vaccines Market Size 2014-2024
        • 2.1.2 Adult and Pediatric Vaccines Market Size CAGR by Region
      • 2.2 Adult and Pediatric Vaccines Segment by Type
        • 2.2.1 Adult Vaccines
        • 2.2.2 Pediatric Vaccines
      • 2.3 Adult and Pediatric Vaccines Market Size by Type
        • 2.3.1 Global Adult and Pediatric Vaccines Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Adult and Pediatric Vaccines Market Size Growth Rate by Type (2014-2019)
      • 2.4 Adult and Pediatric Vaccines Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Medical Care Centers
        • 2.4.3 Others
      • 2.5 Adult and Pediatric Vaccines Market Size by Application
        • 2.5.1 Global Adult and Pediatric Vaccines Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Adult and Pediatric Vaccines Market Size Growth Rate by Application (2014-2019)

      3 Global Adult and Pediatric Vaccines by Players

      • 3.1 Global Adult and Pediatric Vaccines Market Size Market Share by Players
        • 3.1.1 Global Adult and Pediatric Vaccines Market Size by Players (2017-2019)
        • 3.1.2 Global Adult and Pediatric Vaccines Market Size Market Share by Players (2017-2019)
      • 3.2 Global Adult and Pediatric Vaccines Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Adult and Pediatric Vaccines by Regions

      • 4.1 Adult and Pediatric Vaccines Market Size by Regions
      • 4.2 Americas Adult and Pediatric Vaccines Market Size Growth
      • 4.3 APAC Adult and Pediatric Vaccines Market Size Growth
      • 4.4 Europe Adult and Pediatric Vaccines Market Size Growth
      • 4.5 Middle East & Africa Adult and Pediatric Vaccines Market Size Growth

      5 Americas

      • 5.1 Americas Adult and Pediatric Vaccines Market Size by Countries
      • 5.2 Americas Adult and Pediatric Vaccines Market Size by Type
      • 5.3 Americas Adult and Pediatric Vaccines Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Adult and Pediatric Vaccines Market Size by Countries
      • 6.2 APAC Adult and Pediatric Vaccines Market Size by Type
      • 6.3 APAC Adult and Pediatric Vaccines Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Adult and Pediatric Vaccines by Countries
      • 7.2 Europe Adult and Pediatric Vaccines Market Size by Type
      • 7.3 Europe Adult and Pediatric Vaccines Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Adult and Pediatric Vaccines by Countries
      • 8.2 Middle East & Africa Adult and Pediatric Vaccines Market Size by Type
      • 8.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Adult and Pediatric Vaccines Market Forecast

      • 10.1 Global Adult and Pediatric Vaccines Market Size Forecast (2019-2024)
      • 10.2 Global Adult and Pediatric Vaccines Forecast by Regions
        • 10.2.1 Global Adult and Pediatric Vaccines Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Adult and Pediatric Vaccines Forecast by Type
      • 10.8 Global Adult and Pediatric Vaccines Forecast by Application

      11 Key Players Analysis

      • 11.1 GlaxoSmithKline
        • 11.1.1 Company Details
        • 11.1.2 Adult and Pediatric Vaccines Product Offered
        • 11.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 GlaxoSmithKline News
      • 11.2 Sanofi
        • 11.2.1 Company Details
        • 11.2.2 Adult and Pediatric Vaccines Product Offered
        • 11.2.3 Sanofi Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Sanofi News
      • 11.3 Merck
        • 11.3.1 Company Details
        • 11.3.2 Adult and Pediatric Vaccines Product Offered
        • 11.3.3 Merck Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Merck News
      • 11.4 Novartis
        • 11.4.1 Company Details
        • 11.4.2 Adult and Pediatric Vaccines Product Offered
        • 11.4.3 Novartis Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Novartis News
      • 11.5 Pfizer
        • 11.5.1 Company Details
        • 11.5.2 Adult and Pediatric Vaccines Product Offered
        • 11.5.3 Pfizer Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Pfizer News
      • 11.6 AstraZeneca
        • 11.6.1 Company Details
        • 11.6.2 Adult and Pediatric Vaccines Product Offered
        • 11.6.3 AstraZeneca Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 AstraZeneca News
      • 11.7 Johnson and Johnson
        • 11.7.1 Company Details
        • 11.7.2 Adult and Pediatric Vaccines Product Offered
        • 11.7.3 Johnson and Johnson Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Johnson and Johnson News
      • 11.8 Takeda Pharmaceutical
        • 11.8.1 Company Details
        • 11.8.2 Adult and Pediatric Vaccines Product Offered
        • 11.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Takeda Pharmaceutical News
      • 11.9 Bavarian Nordic
        • 11.9.1 Company Details
        • 11.9.2 Adult and Pediatric Vaccines Product Offered
        • 11.9.3 Bavarian Nordic Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Bavarian Nordic News
      • 11.10 LG Life Sciences
        • 11.10.1 Company Details
        • 11.10.2 Adult and Pediatric Vaccines Product Offered
        • 11.10.3 LG Life Sciences Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 LG Life Sciences News
      • 11.11 Sinovac Biotech

      12 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Adult and Pediatric Vaccines . Industry analysis & Market Report on Adult and Pediatric Vaccines is a syndicated market report, published as Global Adult and Pediatric Vaccines Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Adult and Pediatric Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,898.72
      4,348.08
      5,797.44
      3,389.16
      5,083.74
      6,778.32
      553,941.00
      830,911.50
      1,107,882.00
      305,244.00
      457,866.00
      610,488.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report